Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Fundam Clin Pharmacol ; 37(4): 824-832, 2023 Aug.
Article in English | MEDLINE | ID: mdl-36869661

ABSTRACT

The rising of diseases caused by multidrug-resistant bacteria has encouraged researchers to explore more antimicrobial substances, as well as chemicals capable of potentiating the action of existing ones against multidrug-resistant bacteria. Anacardium occidentale produces a fruit known as cashew nut, filled with a dark, almost black, caustic, and flammable liquid called cashew nutshell liquid (CNSL). The goal of the study was to evaluate the intrinsic antimicrobial activity of the major compounds present in CNSL, called anacardic acids (AA), as well as their possible modulatory action as an adjuvant of Norfloxacin against a Staphylococcus aureus strain overproducing the NorA efflux pump (SA1199B). Microdilution assays were performed to determine the minimum inhibitory concentration (MIC) of AA against different microbial species. Norfloxacin and Ethidium Bromide (EtBr) resistance modulation assays were performed in the presence or absence of AA against SA1199-B. AA showed antimicrobial activity against Gram-positive bacterial strains tested but no activity against Gram-negative bacteria or yeast strains. At subinhibitory concentration, AA reduced the MIC values for Norfloxacin and EtBr against the SA1199-B strain. Furthermore, AA increased the intracellular accumulation of EtBr in this NorA overproducer strain, indicating that AA are NorA inhibitors. Docking analysis showed that AA probably modulates Norfloxacin efflux by spatial impediment at the same binding site of NorA.


Subject(s)
Anacardium , Staphylococcal Infections , Norfloxacin/pharmacology , Anti-Bacterial Agents/pharmacology , Staphylococcus aureus , Anacardium/metabolism , Anacardic Acids/pharmacology , Anacardic Acids/metabolism , Multidrug Resistance-Associated Proteins , Staphylococcal Infections/microbiology , Ethidium/metabolism , Ethidium/pharmacology , Microbial Sensitivity Tests
2.
Basic Clin Pharmacol Toxicol ; 120(1): 52-58, 2017 Jan.
Article in English | MEDLINE | ID: mdl-27398818

ABSTRACT

Leishmaniasis is an infectious disease complex caused by protozoa from the Leishmania genus, which presents a broad spectrum of clinical manifestations: cutaneous, mucocutaneous and visceral forms. The current treatments are unsatisfactory considering that few drugs are available and present some level of toxicity. Many lignans and neolignans have been used for the development of new antileishmania drugs. The capability in vitro of the neolignan 2,3-dihydrobenzofuran (2,3-DBF), a commonly found constituent of propolis and other plants, to inhibit the growth of promastigote and macrophage-internalized amastigote forms of Leishmania amazonensis was investigated. The cytotoxicity of this compound was assessed by MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) test in BALB/c murine macrophages and human erythrocyte lysis assay. The 2,3-DBF was active against promastigote (IC50 =1.042 µM) and amastigote (IC50 =1.43 µM) forms, indicating a potent antileishmanial effect. There was no evidence of cytotoxicity to macrophages or erythrocytes at concentrations ranging from 13 to 0.5 µM, after 48 hr of exposure. The antileishmanial activity is probably mediated by the activation of macrophages, because treatment with 2,3-DBF increases both phagocytic and lysosomal activities, as well as the nitrite (NO2- ) levels. These results suggest that 2,3-DBF may be a potential candidate for the development of a new promising antileishmanial drug. Further studies are needed to determine its potential in vivo effect as well as additional mechanisms underlying the antileishmanial and immunomodulatory activities.


Subject(s)
Antiprotozoal Agents/pharmacology , Benzofurans/pharmacology , Leishmania/drug effects , Lignans/pharmacology , Animals , Antiprotozoal Agents/adverse effects , Benzofurans/adverse effects , Erythrocytes/drug effects , Hemolysis/drug effects , Humans , Hydroxylation , Inhibitory Concentration 50 , Leishmania/growth & development , Leishmania/physiology , Lignans/adverse effects , Lysosomes/drug effects , Lysosomes/enzymology , Macrophage Activation/drug effects , Macrophages, Peritoneal/drug effects , Macrophages, Peritoneal/immunology , Macrophages, Peritoneal/metabolism , Macrophages, Peritoneal/parasitology , Mice, Inbred BALB C , Nitric Oxide/agonists , Nitric Oxide/metabolism , Osmolar Concentration , Phagocytosis/drug effects
3.
Nat Prod Res ; 27(4-5): 470-4, 2013 Mar.
Article in English | MEDLINE | ID: mdl-22708546

ABSTRACT

Garcinielliptone FC (GFC), a natural prenylated benzophenone, was extracted from Platonia insignis Mart. (Clusiaceae), a native plant commonly known as bacuri and used in traditional Brazilian medicine for the treatment of skin diseases. The aim of this study was to evaluate the cytotoxic and leishmanicidal effects of GFC using in vitro models. The experimental data demonstrated that the polyisoprenylated benzophenone GFC possesses cytotoxic and leishmanicidal activities.


Subject(s)
Benzophenones/chemistry , Clusiaceae/chemistry , Leishmania/drug effects , Trypanocidal Agents/chemistry , Trypanocidal Agents/pharmacology , Cell Line, Tumor , HT29 Cells , Humans , Triterpenes
4.
Pharm Biol ; 50(4): 453-7, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22129154

ABSTRACT

CONTEXT: Platonia insignis Mart. (Clusiaceae), commonly known as "bacuri," is a timber and fruit native species of the Brazilian Amazon. Some plants of the Clusiaceae family have their pharmacological properties associated with the presence of xanthone and polycyclic polyprenylated acylphloroglucinols derivatives, which have antioxidant and anticarcinogenic activities. OBJECTIVE: The aim of this study was to assess the in vivo potential of extracts, fractions, and garcinielliptone FC isolated from of Platonia insignis seeds as a natural antioxidant. MATERIALS AND METHODS: Male Wistar rats (250-280 g; 2 months old) were treated with Tween 80 0.05% dissolved in 0.9% saline (i.p, vehicle - control group), ethanol extract (EE), hexane extract (HE), dichloromethane fraction (DMF), ethyl acetate fraction (EAF), and garcinielliptone FC (GFC) isolated from P. insignis at doses 2 mg/kg (i.p.). All groups were observed for 24 h after the treatment. The antioxidant enzymatic activities [superoxide dismutase (SOD) and catalase (CAT)] were measured using spectrophotometric methods. RESULTS: There were no marked alterations in SOD and CAT activities in rat hippocampus after pretreatment with EE, HE, DMF, EAF, and GFC. However, the pretreatment with GFC induced a significantly increase of 13, 17, 19, and 13% in SOD activities when compared to EE, HE, DMF, or EAF groups, respectively. DISCUSSION AND CONCLUSION: Our findings strongly support the hypothesis that GFC isolated from P. insignis has a significant potential to be used as a natural antioxidant agent probably due to the modulation of enzymatic activity of hippocampal SOD.


Subject(s)
Antioxidants/pharmacology , Catalase/metabolism , Clusiaceae , Hippocampus/drug effects , Plant Extracts/pharmacology , Superoxide Dismutase/metabolism , Triterpenes/pharmacology , Animals , Antioxidants/chemistry , Antioxidants/isolation & purification , Clusiaceae/chemistry , Dose-Response Relationship, Drug , Hippocampus/enzymology , Male , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Plants, Medicinal , Rats , Rats, Wistar , Seeds , Solvents/chemistry , Spectrophotometry , Time Factors , Triterpenes/isolation & purification , Up-Regulation
SELECTION OF CITATIONS
SEARCH DETAIL
...